You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial
|
|---|---|
| Published in |
Frontiers in Medicine, May 2023
|
| DOI | 10.3389/fmed.2023.1139046 |
| Pubmed ID | |
| Authors |
Tatsuhiko Wada, Makoto Hibino, Hiromi Aono, Shunsuke Kyoda, Yosuke Iwadate, Eri Shishido, Keisuke Ikeda, Nana Kinoshita, Yasuki Matsuda, Sakiko Otani, Ryo Kameda, Kenta Matoba, Miwa Nonaka, Mika Maeda, Yuji Kumagai, Junya Ako, Masayoshi Shichiri, Katsuhiko Naoki, Masato Katagiri, Masashi Takaso, Masatsugu Iwamura, Kazuhiko Katayama, Takeshi Miyatsuka, Yasushi Orihashi, Kunihiro Yamaoka, for the CORVETTE-01 Study Group |
X Demographics
The data shown below were collected from the profiles of 1,814 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 467 | 26% |
| United States | 8 | <1% |
| Austria | 5 | <1% |
| China | 5 | <1% |
| Korea, Democratic People's Republic of | 3 | <1% |
| United Kingdom | 3 | <1% |
| Nepal | 2 | <1% |
| Canada | 2 | <1% |
| Peru | 2 | <1% |
| Other | 19 | 1% |
| Unknown | 1298 | 72% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1797 | 99% |
| Practitioners (doctors, other healthcare professionals) | 8 | <1% |
| Scientists | 8 | <1% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 10 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 2 | 20% |
| Researcher | 2 | 20% |
| Professor | 1 | 10% |
| Unknown | 5 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 3 | 30% |
| Nursing and Health Professions | 1 | 10% |
| Engineering | 1 | 10% |
| Unknown | 5 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1256. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2024.
All research outputs
#11,062
of 25,815,269 outputs
Outputs from Frontiers in Medicine
#8
of 7,330 outputs
Outputs of similar age
#336
of 392,699 outputs
Outputs of similar age from Frontiers in Medicine
#1
of 347 outputs
Altmetric has tracked 25,815,269 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,330 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 392,699 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 347 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.